Ashton Thompson
Psychiatry · Wilton Manors, FLNPI 1891128732
Payments from drug & device makers
Across 114 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch Health US, LLC$488
- Sunovion Pharmaceuticals Inc.$407
- Otsuka America Pharmaceutical, Inc.$394
- Axsome Therapeutics, Inc.$331
- AbbVie$248
- Teva Pharmaceuticals USA, Inc.$222
- plus $751 from 12 others
What the payments were for
- Food & beverage$2,82299%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch Health US, LLC | 36 | $488 |
| Sunovion Pharmaceuticals Inc. | 5 | $407 |
| Otsuka America Pharmaceutical, Inc. | 13 | $394 |
| Axsome Therapeutics, Inc. | 17 | $331 |
| AbbVie(2 entities) | 12 | $248 |
| Teva Pharmaceuticals USA, Inc. | 7 | $222 |
| Alkermes, Inc. | 4 | $176 |
| Johnson & Johnson | 1 | $125 |
| Neurocrine Biosciences, Inc. | 2 | $119 |
| Indivior Inc. | 3 | $64 |
| Orexo US, Inc. | 4 | $62 |
| Sandoz | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Neos Therapeutics, LP | 2 | $37 |
| Neuronetics, Inc. | 1 | $36 |
| Almatica Pharma LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Gilead | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,841 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 12 | $802 |
| Lamotrigine | 38 | $464 |
| Paroxetine Hcl | 24 | $380 |
| Bupropion XlBupropion Hcl | 11 | $361 |
| Fluoxetine Hcl | 13 | $223 |
| Clonazepam | 18 | $206 |
| Olanzapine | 14 | $182 |
| Amitriptyline Hcl | 12 | $88 |
| Zolpidem Tartrate | 13 | $88 |
| Sertraline Hcl | 22 | $72 |
| Trazodone Hcl | 18 | $67 |
| Escitalopram Oxalate | 13 | $66 |
| Alprazolam | 14 | $52 |
| Diazepam | 11 | $19 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $19 | $7222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Wilton Manors
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.